A Critical Analysis of Biomarkers and Diagnostics Strategies for Alzheimer's Syndrome
Open Access
- 9 August 2025
- journal article
- Published by Salud, Ciencia y Tecnologia in Health Leadership and Quality of Life
- Vol. 4, 773
Abstract
These analyses assess the early recognition and prediction of Alzheimer's disease (AD) by investigative biomarkers in the prodromal and transitional stages. The traditional diagnostic technique often fails to detect subtle cognitive modifications in the early stages, which leads to delayed interference and behavior. Data were gathered from 350 participants diagnosed with mild cognitive impairment (MCI), including cerebrospinal fluid (CSF) biomarker levels, neuroimaging scans, and clinical assessment. The research employs three Statistical analyses, using IBM SPSS Statistics version 30 including analyze the predictive validity of these biomarkers: regression analysis, and survival analysis. Regression analysis exposed a strong relationship between tau protein levels and the expansion from MCI to AD, with a coefficient of determination, representative of the power of CSF biomarkers in predicting AD onset. Survival analysis using Kaplan-Meier curves showed that participants with elevated amyloid plaque accumulation had a considerably higher risk of transitioning to AD. The researches underscore the limitations of the traditional diagnostic approach and emphasizes the importance of integrating other statistical method to improve early diagnosis. These findings suggest that refined statistical frameworks are crucial for enhancing the accuracy of AD diagnosis and advancing targeted treatment strategy.Keywords
This publication has 16 references indexed in Scilit:
- Revised criteria for diagnosis and staging of Alzheimer's disease: Alzheimer's Association WorkgroupAlzheimer's & Dementia, 2024
- Circular RNAs in Alzheimer’s Disease: A New Perspective of Diagnostic and Therapeutic TargetsCNS & Neurological Disorders - Drug Targets, 2023
- Recent advances in Carbon Nanotube Based Field-Effect Transistor Biosensors for Established Biomarkers for the Diagnosis of Alzheimer's DiseaseChemRxiv, 2023
- The neuroimmune axis of Alzheimer’s diseaseGenome Medicine, 2023
- Association between anxiety symptoms and Alzheimer's disease biomarkers in cognitively healthy adults: A systematic review and meta-analysisJournal of Psychosomatic Research, 2023
- Multipronged diagnostic and therapeutic strategies for Alzheimer's diseaseChemical Science, 2022
- Using the Alzheimer's Disease Neuroimaging Initiative to improve early detection, diagnosis, and treatment of Alzheimer's diseaseAlzheimer's & Dementia, 2021
- Nanomedicine-based technologies and novel biomarkers for the diagnosis and treatment of Alzheimer’s disease: from current to future challengesJournal of Nanobiotechnology, 2021
- Practical recommendations for timely, accurate diagnosis of symptomatic Alzheimer’s disease (MCI and dementia) in primary care: a review and synthesisJournal of Internal Medicine, 2021
- Surface plasmon resonance biosensors for detection of Alzheimer's biomarkers; an effective step in early and accurate diagnosisBiosensors and Bioelectronics, 2020